Susquehanna International Group
KYNB

Susquehanna International Group’s Kyntra Bio KYNB Stock Holding History

Susquehanna International Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$606K Sell
89,400
-145,900
-62% -$1.14M ﹤0.01% 9167
2025
Q4 		$2.07M Hold
235,300
– – ﹤0.01% 5589
2025
Q3 		$2.88M Sell
235,300
-38,100
-14% -$358K ﹤0.01% 5052
2025
Q2 		$1.45M Buy
273,400
+263,960
+2,796% +$1.93M ﹤0.01% 6535
2025
Q1 		$73.2K Buy
9,440
+2,944
+45% +$35.3K ﹤0.01% 11722
2024
Q4 		$86.1K Sell
6,496
-2,704
-29% -$25.1K ﹤0.01% 11430
2024
Q3 		$92K Sell
9,200
-5,156
-36% -$77.8K ﹤0.01% 11098
2024
Q2 		$319K Buy
14,356
+4,492
+46% +$139K ﹤0.01% 9311
2024
Q1 		$580K Buy
+9,864
New +$425K ﹤0.01% 8152
2023
Q4 		– Sell
-1,452
Closed -$31.2K – 12626
2023
Q3 		$31.2K Sell
1,452
-33,904
-96% -$1.33M ﹤0.01% 11472
2023
Q2 		$2.39M Buy
35,356
+28,140
+390% +$11.6M ﹤0.01% 4789
2023
Q1 		$3.37M Sell
7,216
-956
-12% -$506K ﹤0.01% 4091
2022
Q4 		$3.27M Sell
8,172
-1,052
-11% -$403K ﹤0.01% 3871
2022
Q3 		$3M Sell
9,224
-448
-5% -$144K ﹤0.01% 4093
2022
Q2 		$2.55M Buy
9,672
+5,544
+134% +$1.42M ﹤0.01% 4388
2022
Q1 		$1.24M Sell
4,128
-620
-13% -$216K ﹤0.01% 6596
2021
Q4 		$1.67M Sell
4,748
-132
-3% -$41.1K ﹤0.01% 5938
2021
Q3 		$1.25M Sell
4,880
-200
-4% -$70.9K ﹤0.01% 6983
2021
Q2 		$3.38M Buy
5,080
+1,284
+34% +$740K ﹤0.01% 4771
2021
Q1 		$3.29M Sell
3,796
-920
-20% -$980K ﹤0.01% 4756
2020
Q4 		$4.37M Buy
4,716
+952
+25% +$1M ﹤0.01% 3641
2020
Q3 		$3.87M Buy
3,764
+1,188
+46% +$1.28M ﹤0.01% 3426
2020
Q2 		$2.61M Buy
2,576
+596
+30% +$553K ﹤0.01% 4031
2020
Q1 		$1.72M Buy
1,980
+1,064
+116% +$1.06M ﹤0.01% 4237
2019
Q4 		$982K Sell
916
-644
-41% -$657K ﹤0.01% 5566
2019
Q3 		$1.44M Sell
1,560
-604
-28% -$663K ﹤0.01% 4906
2019
Q2 		$2.44M Sell
2,164
-4,868
-69% -$5.33M ﹤0.01% 3788
2019
Q1 		$9.55M Buy
7,032
+3,412
+94% +$4.63M ﹤0.01% 1777
2018
Q4 		$4.19M Buy
3,620
+1,916
+112% +$2.15M ﹤0.01% 2496
2018
Q3 		$2.59M Sell
1,704
-2,448
-59% -$3.77M ﹤0.01% 3595
2018
Q2 		$6.5M Buy
4,152
+1,164
+39% +$1.52M ﹤0.01% 2425
2018
Q1 		$3.45M Sell
2,988
-16
-0.5% -$21.1K ﹤0.01% 3034
2017
Q4 		$3.56M Buy
3,004
+900
+43% +$1.13M ﹤0.01% 2969
2017
Q3 		$2.83M Buy
2,104
+1,804
+601% +$1.9M ﹤0.01% 3315
2017
Q2 		$242K Sell
300
-1,156
-79% -$805K ﹤0.01% 7963
2017
Q1 		$897K Sell
1,456
-2,044
-58% -$1.24M ﹤0.01% 5353
2016
Q4 		$1.87M Buy
3,500
+1,752
+100% +$875K ﹤0.01% 4208
2016
Q3 		$905K Buy
1,748
+136
+8% +$64.1K ﹤0.01% 4984
2016
Q2 		$661K Sell
1,612
-2,636
-62% -$1.21M ﹤0.01% 5637
2016
Q1 		$2.26M Buy
4,248
+2,680
+171% +$1.34M ﹤0.01% 3537
2015
Q4 		$1.19M Sell
1,568
-420
-21% -$279K ﹤0.01% 5070
2015
Q3 		$1.09M Sell
1,988
-608
-23% -$368K ﹤0.01% 5564
2015
Q2 		$1.52M Buy
+2,596
New +$1.51M ﹤0.01% 5286

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's KYNB Position: Q2 2025 in Review

Susquehanna International Group sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 2,327 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in KYNB in Q4 2014 and held it in 36 quarters. The position peaked at $22.4M in Q4 2018. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Susquehanna International Group reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,327 Kyntra Bio shares in Q2 2025, an estimated $17K.
  • Susquehanna International Group first reported a position in Kyntra Bio in Q4 2014 and held it in 36 quarters.
  • Susquehanna International Group's Kyntra Bio position peaked at $22.4M in Q4 2018.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.